MedTrace Logo

Therapeutic Effectiveness of Vardenafil in Patients With Erectile Dysfunction and Metabolic Syndrome in Daily Clinical Practice

NCT01106118 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2289

Last updated 2016-10-17

No results posted yet for this study

Summary

The primary goal of this international non-interventional study is to investigate the therapeutic effectiveness of vardenafil (film-coated tablet) in Erectile Dysfunction patients with the Metabolic Syndrome in daily clinical practice. It will include a large number of patients with various underlying conditions with different cultural and demographic backgrounds from different geographic areas.

Conditions

Interventions

DRUG

Vardenafil (Levitra, BAY38-9456)

Patients with diagnosis of erectile dysfunction and metabolic syndrome who get vardenafil in routine treatment as prescribed by physician

Sponsors & Collaborators

Principal Investigators

  • Bayer Study Director · Bayer

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-01-31
Primary Completion
2012-12-31
Completion
2013-08-31

Countries

  • Egypt
  • Israel
  • Kazakhstan
  • Kyrgyzstan
  • Lebanon
  • Russia
  • Saudi Arabia
  • Singapore
  • South Korea
  • Ukraine

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01106118 on ClinicalTrials.gov